Diyabet Cerrahisi
Özet
Dünya genelinde obezite ve buna bağlı Tip 2 Diabetes Mellitus (T2DM) prevalansındaki artış epidemik bir boyuta ulaşmıştır. Obezite ile mücadelede ve kilo kaybı sağlamada en etkili yöntem bariatrik cerrahidir. T2DM ve ilişkili metabolik durumların tedavisini hedefleyen bu prosedürler metabolik cerrahisi (MC) olarak tanımlanmaktadır. MC; glisemik kontrolü sağlama, sürekli kilo kaybı ve diyabet komorbiditelerini azaltmada yaşam tarzı değişiklikleri veya tıbbi tedavilere kıyasla üstün etkinlik göstermektedir. Diyabet, mikrovasküler ve makrovasküler komplikasyonlar riski taşıyan, çoklu organ disfonksiyonuna yol açabilen kronik bir hastalıktır. Tedavide sağlıklı yaşam tarzı, diyet ve risk faktörlerinin yönetimi temel basamakları oluştursa da özellikle morbid obez bireylerde uzun vadeli başarı için cerrahi müdahale öne çıkmaktadır. Günümüzde Sleeve Gastrektomi (SG) ve Roux-en-Y Gastrik Bypass (RYGB) en sık uygulanan, minimal invaziv, güvenli ve maliyet-etkin bariatrik yöntemlerdir. Bu cerrahi prosedürler, malabsorbsiyon ve hacim kısıtlamasının yanı sıra endokrin değişiklikler tetikleyerek yüksek oranlarda diyabet remisyonu sağlamakta ve hastaların mortalite oranını bariz şekilde düşürmektedir.
The global rise in obesity and related Type 2 Diabetes Mellitus (T2DM) prevalence has reached epidemic proportions. Bariatric surgery is proven to be the most effective method for managing obesity and achieving sustainable weight loss. Metabolic surgery (MC) describes these procedures primarily used to treat T2DM and associated metabolic conditions. MC demonstrates superior efficacy over lifestyle modifications or medical management in achieving glycemic control, sustained weight loss, and reducing diabetic comorbidities. Diabetes is a chronic disease associated with microvascular and macrovascular complications that can lead to multi-organ dysfunction. Although a healthy lifestyle, diet, and risk factor management form the foundational treatment steps, surgical intervention stands out for long-term success, particularly in morbidly obese individuals. Currently, Sleeve Gastrectomy (SG) and Roux-en-Y Gastrik Bypass (RYGB) are the most commonly performed, minimally invasive, safe, and cost-effective bariatric procedures. These interventions trigger endocrine changes alongside malabsorption and volume restriction, leading to high rates of diabetes remission and significantly reducing patient mortality.
Referanslar
Diabetes UK . Diabetes history. 2019.
Karamanou M, Protogerou A, Tsoucalas G, Androutsos G, Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: the main contributors. World J Diabetes. 2016;7(1):1–7.
UK D . Diabetes history. 2019.
Today MN. Diabetes: past treatments, new discoveries. 2021.
Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: a review. Int J Health Sci (Qassim) 2017;11(2):65–71.
American Diabetes Association 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-27.
American Diabetes Association 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S61-70.
White JR., Jr A brief history of the development of diabetes medications. Diab Spectr. 2014;27(2):82–86.
Association AD 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Supplement 1):S8. [Google Scholar]
American Diabetes A Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–SS9. [PMC free article] [PubMed] [Google Scholar]
DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–2462. [PMC free article] [PubMed] [Google Scholar]
Rogers MAM, Kim C, Banerjee T, Lee JM. Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med. 2017;15(1):199.
Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66(2):241–255
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.
UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance. Diabetologia. 1991;34(12):877–890. [PubMed] [Google Scholar]
Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767–780.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589.
Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds. 2005;4(3):154
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119(2):351–357.
Zhang Y, Pan XF, Chen J, Xia L, Cao A, Zhang Y, et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia. 2020;63(1):21–33.
Engler PA, Ramsey SE, Smith RJ. Alcohol use of diabetes patients: the need for assessment and intervention. Acta Diabetol. 2013;50(2):93–9.
Chang SA. Smoking and type 2 diabetes mellitus. Diabetes Metab J. 2012; 36(6):399–403
Jee SH, Foong AW, Hur NW, Samet JM. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care. 2010; 33(12):2567–72
Tetzschner R, Nørgaard K, Ranjan A. Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-a systematic review with GRADE. Diabetes Metab Res Rev. 2018;34(3).
Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and metaanalysis. Diabetes Care. 2009;32(11):2123–32
Polsky S, Akturk HK. Alcohol consumption, diabetes risk, and cardiovascular disease within diabetes. Curr Diab Rep. 2017;17(12):136.
Guo Y, Huang Z, Sang D, Gao Q, Li Q. The role of nutrition in the prevention and intervention of type 2 diabetes. Front Bioeng Biotechnol. 2020;8:575442.
Panagiotakos DB, Tzima N, Pitsavos C, Chrysohoou C, Papakonstantinou E, Zampelas A, et al. The relationship between dietary habits, blood glucose and insulin levels among people without cardiovascular disease and type 2 diabetes; the ATTICA study. Rev Diabet Stud. 2005;2(4):208–215.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–651.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014;370(21):2002–2013.
Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. Jama. 2014;311(22):2297–2304.
Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med 2011;28:628-642. http://dx.doi.org/10.1111/j.1464-5491.2011.03306.x
Shabbir A, Teh JL. A New Emerging procedure - Sleeve Gastrectomy. In: Essentials and Controversies in Bariatric Surgery. InTech; 2014
Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev. 2012;13:316–328.
Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000;10:233-239. http://dx.doi.org/10.1381/096089200321643511
5. Powell M, Fernandez AZ. Surgical Treatment for Morbid Obesity: The Laparoscopic Roux-en-Y Gastric Bypass. Surg Clin N Am 2011;91:1203-1224. http://dx.doi.org/10.1016/j.suc.2011.08.013
Schirmer B, Schauer PR. The surgical management of obesity. Schwart’s Principles of Surgery 2010; 949-978
